LEIDEN JEFFREY M sold VRTX
December 3, 2025 · Form 4 insider transaction
LEIDEN JEFFREY M sold 10,360 shares of Vertex Pharmaceuticals Incorporated at $453.34 per share, a transaction worth $4.70M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1, which was entered into on 8/6/2025.; Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.; Open market sales reported on this line occurred at a weighted average price of $453.34 (range $452.91 to $453.70).